Vivo Capital

Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:

Vivo Capital portfolio companies for March 2017 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Aclaris Therapeutics 25.08 2.86M -12.00% 29.82 0.00
Ascendis Pharma A S 14.56 1.77M 28.00 0.00
Nabriva Therapeutics Ag 14.20 4.02M 12.00 0.00
Codexis Inc 7.48 5.29M 4.80 0.00
Eiger Biopharmaceuticals 6.02 1.79M 11.45 0.00
Advanced Accelerat spon ads each rep 2 ord shs 5.67 483786 +6.00% 39.86 0.00
Aimmune Therapeutics 4.88 763009 21.73 0.00
Strongbridge Bioph shs usd 4.19 3.00M 4.75 0.00
Capnia 3.07 14.70M +97.00% 0.71 0.00
Biopharmx 1.89 12.81M 0.50 0.00
Trevena 1.87 1.73M 3.67 0.00
Akari Therapeutics 1.72 527842 11.07 0.00
Agile Therapeutics 1.43 1.51M 3.20 0.00
Aurinia Pharmaceuticals 1.30 600000 NEW 7.34 0.00
Foamix Pharmaceuticals Ltd shs 1.25 855000 4.95 0.00
Sierra Oncology 1.10 2.44M NEW 1.53 0.00
Crispr Therapeutics Ag 0.95 148878 21.77 0.00
Regenxbio Inc equity us cm 0.93 164403 -67.00% 19.30 0.00
Kalvista Pharmaceuticals 0.69 300325 7.81 0.00
Dynavax Technologies 0.63 359828 5.95 0.00
Sunesis Pharmaceuticals Inc Ne 0.60 500000 4.10 0.00
Revance Therapeutics 0.47 77373 20.80 0.00
Capnia Inc Common Stock Warrants 0.03 943858 0.12 0.00

Past 13F-HR SEC Filings for Vivo Capital

View All Filings